Related Experiment Videos
[Carcinogenesis in familial polyposis coli].
1Dept. of Genetics, Kyushu University, Fukuoka.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 1, 1989
Summary
Familial polyposis coli (FPC) is a model for colorectal cancer and carcinogenesis. Genetic alterations in FPC, including oncogene activation and tumor suppressor gene inactivation, drive tumor progression from adenoma to malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Familial polyposis coli (FPC) serves as a crucial model for understanding colorectal cancer progression.
- Elucidating the general molecular mechanisms of carcinogenesis.
Purpose:
- To review recent advancements in the molecular mechanisms of tumorigenesis in FPC.
- To detail genetic alterations involved in FPC tumor development.
Summary:
- The FPC major gene, located on chromosome 5q, is implicated as an early event in initiating hyperproliferation for adenoma formation.
- Tumorigenesis in FPC involves genetic alterations such as oncogene activation (e.g., mutated ras genes) and tumor suppressor gene inactivation (e.g., loss of heterozygosity).
- Adenomas progress to malignancy through multiple gene and chromosome mutations.
Impact:
- Provides insights into the molecular basis of inherited colorectal cancer.
- Contributes to a broader understanding of cancer development and progression.
- Highlights the role of specific genetic mutations in tumor initiation and advancement.